ABOUT US:

Unimark Remedies Ltd. (“URL”) is a Research Driven Pharmaceutical Company primarily engaged in the manufacturing of APIs and Advanced Intermediates. Since 1995 company has developed vast skills in the areas of Process R & D, Process Chemistry Skills, Handling Complex Chemical Reactions and expertise in marketing of APIs and Specialty Intermediates in India and Globally.
In a challenging economic environment Unimark Remedies Ltd. has emerged as a leading manufacturer of Active Pharmaceutical Ingredients (APIs) and Specialty Intermediates in India with estimated Sales Turnover of approx. US $ 90 Million.
URL was incepted in 1984 as the exclusive Marketing Agent for Pfizer, BASF, UB Petro Products. URL’s core competence in marketing and logistics facilitated inroads to successfully access more than 75% of the domestic pharma market in value terms of its range of products.
In 1996, URL entered the API manufacturing Activity as part of backward integration with an emphasis on cost effective process and economics of scale. URL has successfully grown this business to US $ 90 Million. URL has today strategically positioned itself as a non competing supplier to Global players such as Ranbaxy, West-ward Pharm, Pfizer (USA), GSK (UK), Apotex, Watson (USA), Shinpoong (Korea), CKD (Korea), Canada and other Pharma majors.
NET WORTH:
As of 31/03/2006 the Net worth of the company is US $ 20 Million

• Oxacillin Sodium
• Albendazole
• Benazepril
• Lisinopril
• Ramipril
• Flecainide Acetate
• Nalidixic Acid
• Meloxicam
• Nimesulide
• Dextropropoxyphene HCL
• Montelukast Sodium
• Topiramate
• Mefloquine
• Ceftezole
• Cefmetazole
• Ertapenem
• Meropenem